The Epidemiology of Venous Thromboembolism in the Community
Top Cited Papers
- 1 January 2001
- journal article
- research article
- Published by Georg Thieme Verlag KG in Thrombosis and Haemostasis
- Vol. 86 (07), 452-463
- https://doi.org/10.1055/s-0037-1616243
Abstract
The incidence of venous thromboembolism exceeds 1 per 1000; over 200,000 new cases occur in the United States annually. Of these, 30% die within 30 days; one-fifth suffer sudden death due to pulmonary embolism. Despite improved prophylaxis, the incidence of venous thromboembolism has been constant since 1980. Independent risk factors for venous thromboembolism include increasing age, male gender, surgery, trauma, hospital or nursing home confinement, malignancy, neurologic disease with extremity paresis, central venous catheter/ transvenous pacemaker, prior superficial vein thrombosis, and varicose veins; among women, risk factors include pregnancy, oral contraceptives, and hormone replacement therapy. About 30% of surviving cases develop recurrent venous thromboembolism within ten years. Independent predictors for recurrence include increasing age, obesity, malignant neoplasm, and extremity paresis. About 28% of cases develop venous stasis syndrome within 20 years. To reduce venous thromboembolism incidence, improve survival, and prevent recurrence and complications, patients with these characteristics should receive appropriate prophylaxis. * Present address: Dr. Silverstein, Medical University of South Carolina, Center of Health Care Research, 171 Ashley Avenue, Charleston, South Carolina 55905, USAKeywords
Funding Information
- National Institutes of Health (HL 46974, HL66216, and AR 30582)
This publication has 41 references indexed in Scilit:
- Risk of venous thromboembolism among users of third generation oral contraceptives compared with users of oral contraceptives with levonorgestrel before and after 1995: cohort and case-control analysisBMJ, 2000
- Epidemiology of Oral Contraceptives and Cardiovascular DiseaseAnnals of Internal Medicine, 1998
- Hormone Replacement Therapy and the Risk of Hospitalization for Venous Thromboembolism: A Population-based Study in Southern EuropeAmerican Journal of Epidemiology, 1998
- Risk of venous thromboembolism in users of hormone replacement therapyThe Lancet, 1996
- The Long-Term Clinical Course of Acute Deep Venous ThrombosisAnnals of Internal Medicine, 1996
- A prospective study of the incidence of deep‐vein thrombosis within a defined urban populationJournal of Internal Medicine, 1992
- Estrogen replacement therapy and the risk of venous thrombosisAmerican Journal Of Medicine, 1992
- Pulmonary embolism and thrombophlebitis in the United States, 1970–1985American Heart Journal, 1987
- The Patient Record in EpidemiologyScientific American, 1981
- Venous Thromboembolism and Other Venous Disease in the Tecumseh Community Health StudyCirculation, 1973